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High-affinity binding between nanoscale objects is an essential prerequisite for “bottom-up” 
fabrication.1 In recent years, interest has focused on the use of dendritic macromolecules as 
supramolecular nanoscale building blocks.2 The branched superstructure of dendrons and 
dendrimers offers specific advantages, for example, enhancement of weak binding by using 
multivalent arrays of recognition units on the dendritic surface. This multivalency principle, in which 
organized arrays amplify the strength of a weak binding process, such as the binding of saccharides 
to proteins on cell surfaces, is now well established.3 
DNA constitutes a particularly interesting target for nanotechnological exploitation.4 High-affinity 
binding of DNA is useful for protecting DNA and ultimately for delivering genetic information into 
cells.5 Noncovalent interactions between dendritic macromolecules and DNA are, therefore, of 
considerable current interest.6 Polyamidoamine (PAMAM) dendrimers were the first systems to be 
investigated,7 while dendritic poly(L-lysine)8 and poly(propylene imine)9 have also been studied 
recently. In general, higher-generation, or structurally fractured, systems are usually more effective 
for DNA binding and delivery. In an important recent study, however, Diederich and co-workers 
reported low-molecular-mass dendrons designed to self-assemble with DNA, which were capable of 
gene therapy.10 
The interaction between a single protonated amine and the phosphate backbone of DNA is relatively 
weak and must compete with salt binding under biological conditions. Biology therefore uses 
tetraamines, such as spermine (Scheme 1), to achieve DNA binding.11 Synthetic spermine 
derivatives are also widely used for applications in DNA binding and delivery.12 However, although 
spermine is better than an isolated amine for binding DNA, the interaction is still relatively weak and 
the complex is mobile. Consequently, spermine struggles to compete with DNA-bound inorganic 
cations.13 
 
Scheme 1. Spermine and target spermine derivatives G0, G1, and G2. 
We became interested in optimizing DNA binding and developing low-molecular-mass dendrons 
with very high affinities for DNA—such systems would be particularly useful for DNA encapsulation 
and protection.14 We therefore decided to develop dendrons that express multivalent spermine 
arrays on their surfaces. Some previously reported multivalent spermine arrays comprised multiple 
spermine groups grafted onto dextran polymers;15 however, we wanted to develop multivalent 
systems with well-defined molecular structures. Such monodisperse systems enable an 
understanding of structure–activity relationships and, in addition, have a greater chance of being 
licensed for therapeutic applications in the longer term. Herein, we report on multivalent dendritic 
spermine constructs with extremely high, salt-independent binding affinities for DNA. 
We used a divergent synthetic approach to construct target compounds G1 and G2 (Scheme 1, 
details of the synthesis can be found in the Supporting Information). Newkome-type branching16 
was used as the dendritic scaffold, as such structures are readily synthesized17 and should be 
biocompatible. After dendron synthesis, the surface was functionalized with spermine groups which 
had been appropriately protected by using the methodology of Blagbrough and Geall.18 
Deprotection of the spermine groups with HCl gas then yielded target compounds G1 and G2. Model 
compound G0 was constructed by using a similar approach (Scheme 1). All synthetic steps were high 
yielding and all target compounds and intermediates were fully characterized with standard 
methods (see the Supporting Information). 
Initially, the binding of the spermine derivatives to DNA was studied by using an ethidium bromide 
displacement assay. This method is commonly used to study the binding of polyammonium 
compounds to DNA.19 The displacement of ethidium bromide from its complex with DNA can be 
monitored because it has enhanced fluorescence when intercalated. This is a powerful comparative 
method, although the resulting data reflect a competition assay, rather than an absolute binding 
strength, and furthermore give no information about binding stoichiometry. 
Fluorescence titrations were performed in buffered water at pH 7.2 using G0, G1, G2, and spermine 
itself. The resultant titration profiles are shown in Figure 1. At this physiologically relevant pH value, 
the spermine groups are largely protonated whilst the DNA is largely deprotonated, so electrostatic 
interactions are maximized. 
 
 
Figure 1. Fluorescence titration profiles for the addition of spermine, G0, G1, or G2 to a solution of 
calf thymus DNA and ethidium bromide in buffered water (pH 7.2) in the presence of 150 mM NaCl. 
The data can be presented in terms of C50 and CE50 values (Table 1). C50 values report the 
concentration of polyamine causing a 50 % decrease in fluorescence intensity. CE50 values represent 
the “charge excess”20 required to achieve the same 50 % reduction in fluorescence—the very best 
DNA binders should have CE50 values below 1.0. Spermine binds to DNA with moderate strength 
under low-salt (9.4 mM NaCl) conditions (C50=1.33 μM, CE50=5.3), but a very large charge excess 
would have been required at physiological salt concentrations (150 mM NaCl) in order to achieve 
50 % quenching of ethidium bromide fluorescence (C50=390 μM, CE50=1560). These results were in 
good agreement with literature data.19a Compound G0 showed similar, if slightly weaker, DNA 
binding. This was expected, as one of the primary amines of spermine has been converted into an 
amide, which is incapable of protonation, and G0 should therefore exhibit weaker electrostatic 
interactions with polyanionic DNA. 
Table 1. Results for spermine, G0, G1, and G2 from an ethidium bromide displacement assay.[a] 
Compound [NaCl] [mM] Nominal charge C50 [μM] CE50 
1. [a] Conditions: Measurements performed in buffered water at pH 7.2 (with 2 mM 2-[4-
(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES) and 0.05 mM 
ethylenediaminetetraacetic tetraacetate (EDTA)). The calf thymus DNA (1 μM) and ethidium 
bromide (1.26 μM) concentrations were kept constant. The total added polyamine solution did 
not exceed 5 % of the total volume; therefore, corrections were not made for sample dilution. 
Results are an average of at least three titrations. Experimental errors ≤10 %. 
spermine 9.4 4+ 1.33 5.3 
G0 9.4 3+ 20 60 
G1 9.4 9+ 0.076 0.68 
G2 9.4 27+ 0.030 0.81 
      
spermine 150 4+ 390 1560 
G0 150 3+ 220 660 
G1 150 9+ 0.300 2.70 
G2 150 27+ 0.028 0.76 
The dendritic systems G1 and G2 showed significantly enhanced DNA binding. Under low-salt 
conditions, G1 effectively displaced ethidium bromide from DNA (C50=76 nM, CE50=0.68). Notably, 
the affinity for DNA is considerably more than three times higher than that of G0. This indicates that 
the organization of three spermine units on the dendritic framework enables DNA-binding activity 
that is more than the simple sum of its individual parts—the multivalency principle3 in operation. 
Compound G1 is somewhat affected by the increase in salt concentration but still shows reasonable 
binding under these conditions (C50=300 nM, CE50=2.70). 
Compound G2 shows a similar binding affinity to G1 under low-salt conditions (C50=30 nM, 
CE50=0.81) but demonstrates its power at physiological salt concentrations, where the binding 
remains just as strong (C50=28 nM, CE50=0.76). The binding is therefore salt independent—a 
proactive dendritic effect. The multivalent system can therefore compete with Na+ ions for binding 
sites on the surface of the DNA helix. Indeed, compound G2 exhibits one of the best binding profiles 
reported by using this method, thereby proving that the strategy of organizing spermine units into a 
well-defined multivalent array has considerable power. 
Gel electrophoresis was used to confirm the affinities of the dendrons for DNA in a direct binding 
assay. The dendritic constructs G1 and G2 retarded the electrophoretic mobility of DNA as a 
consequence of charge neutralization, whilst the spermine and G0 analogues were ineffective 
(Figure 2). The CE values at which mobility was retarded were in agreement with the results of the 
ethidium bromide displacement assays. 
 
Figure 2. Gel electrophoresis of plasmid DNA (250 ng per lane). Lane 1: Plasmid DNA. Lane 2: Plasmid 
DNA + spermine (250 ng). Lane 3: Plasmid DNA + G0 (250 ng). Lane 4: Plasmid DNA + G1 (250 ng). 
Lane 5: Plasmid DNA + G2 (250 ng). 
Finally, transmission electron microscopy (TEM) was used to image the complexes (Figure 3). The 
addition of spermine at CE=1.8 to plasmid DNA in buffered water (pH 7.1, [NaCl]=9.4 mM) prior to 
deposition on a carbon-coated copper grid gave rise to large unsymmetrical aggregates 
approximately 250 nm in diameter (Figure 3 A). Compound G0, however, led to little or no 
compaction of DNA under the same conditions. On the other hand, use of G1 or G2 (CE=2.7) gave 
rise to well-defined, approximately spherical nanoscale complexes (G1: approximately 100 nm in 
diameter; G2: approximately 400 nm in diameter) with no free plasmid being detected (Figures 
3 B, C3). The size range of the aggregates formed was relatively large. Nonetheless, these 
observations indicate that compounds G1 and G2 efficiently bind DNA and condense it into 
approximately spherical complexes. 
 
 
 
 
 
Figure 3. TEM images of DNA in the presence of A) spermine (CE=1.8), B) G1 (CE=2.7), or C) G2 
(CE=2.7). Samples were deposited from buffered water (pH 7.1). 
In summary, we have reported novel dendrons that bind DNA with remarkably high affinities. 
Notably, G2 showed salt-independent DNA binding and it was a factor of ten more effective than the 
G1 analogue under high-salt conditions, whilst G1 was, in turn, significantly more effective than the 
G0 analogue. It can be concluded that the expression of multiple spermine units, nature's own DNA 
binder, on the surface of a dendritic scaffold offers a powerful approach for achieving high-affinity 
DNA binding under physiological conditions. These molecules have potential for further synthetic 
variation, and in current and future work, we will be investigating the effect of structural 
modifications on DNA binding and nanoscale assembly, as well as looking at applications of the novel 
dendritic constructs in gene protection and delivery. 
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